Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Aksense logo — Point-of-Care Testing for Infectious Diseases

Aksense

Point-of-Care Testing for Infectious Diseases

Founded 2017 Turkey Turkey 4 employees Seed Total: $160.00K Health Care, Medical Devices

General Information

Company Name Aksense
Founded Year 2017
Location Turkey Turkey
Employees 4
Industries Health Care, Medical Devices
Funding Stage Seed
Business Model B2B
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Aksense. To contact Aksense, visit aksense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aksense compare?

A PDF of Aksense and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aksense soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aksense

Aksense, founded in 2017, is an innovator in the Health Care and Medical Devices sectors, with headquarters in Turkey. The company is making significant strides in the medical field with its pioneering product—an electronic biosensor aimed at Point-of-Care Testing for Infectious Diseases.

Aksense's flagship device facilitates rapid, one-minute blood tests for healthcare-associated infections, eliminating the need for a lab or expert intervention. This not only stands to save lives but also reduces time and healthcare costs, presenting a significant value proposition for healthcare providers globally.

Following a successful Seed Round investment on 09 May 2022, backed by SOSV, Aksense is well-positioned to expand its market reach and continue its development efforts. Investors should note the company's potential to disrupt traditional infection testing processes with its portable and time-efficient solution.

Business keywords: Point-of-Care Testing, Healthcare-Associated Infections, Rapid Diagnostic Testing, Electronic Biosensor, Portable Medical Device, Infection Detection, Biotechnology Innovation, Medical Device Development, Infectious Disease Management, Blood Test Innovation, Life-Saving Technology, Cost-Effective Healthcare Solutions

Services & Products

Rapid Diagnosis in Minutes
Portable Diagnostic Device
Accurate Infection Identification

Target Customers

Healthcare Providers Hospitals Long-term Care Facilities Clinics

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
SOSV
SOSV
09 May 2022
Seed Round Undisclosed -
15 Jan 2020
Pre Seed Round $160.00K 1
SOSV
SOSV
16 Oct 2019
Non Equity Assistance Undisclosed 1
Hackquarters
Hackquarters
05 Jan 2019

Aksense Alternatives & Competitors

View All Alternatives
Aksense vs
i-SENS, Inc.
i-SENS, Inc. Korea South

i-SENS is a global company dedicated to improving the lives of people with diabetes and those who ca...

Series A
106 employees
Health Care, Manufacturing
Aksense vs
Avails Medical, Inc.
Avails Medical, Inc. United States

Avails Medical, Inc. - Affordable & Rapid Antibiotic Susceptibility Testing for clinical laboratorie...

Grant
51 employees
Health Care, Medical Devices
Aksense vs
Astek Diagnostics
Astek Diagnostics United States

One-hour antibiotic sensitivity testing

Non Equity Assistance
14 employees
Health Care, Medical Devices
View all alternatives

FAQ About Aksense

Point-of-Care Testing for Infectious Diseases
Aksense was founded in 2017.
Aksense is headquartered in Turkey.
Aksense operates in Health Care and Medical Devices. Its work centres on Point-of-Care Testing, Healthcare-Associated Infections, Rapid Diagnostic Testing and Electronic Biosensor. Its customers include Healthcare Providers, Hospitals and Long-term Care Facilities.
Aksense has a B2B business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Aksense has approximately 4 employees.
Aksense has completed 4 funding rounds, raising a total of $160.00K. The latest funding stage is Seed.
Aksense offers: Rapid Diagnosis in Minutes, Portable Diagnostic Device, Accurate Infection Identification.
Top alternatives and competitors to Aksense include i-SENS, Inc. , Avails Medical, Inc., Astek Diagnostics, EMPE Diagnostics, SpinChip Diagnostics ASA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aksense and i-SENS, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aksense, https://bouncewatch.com/company/aksense, updated 26 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes